First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

FHS
June 22, 2023
11:09 pm

Cartesian Therapeutics, a clinical-stage biotechnology company pioneering cell therapies for autoimmune diseases, announced today the publication of a landmark paper in The Lancet Neurology.

Sanofi, Formation Bio, OpenAI Partner on AI-Powered Drug Discovery

What You Should Know: – Sanofi, a global pharmaceutical leader, Formation Bio, an AI-powered drug developer, and OpenAI, a leading research and development company in

May 21, 2024

Two GSK trials with long-acting drug in chronic rhinosinusitis hit primary endpoints

GSK announced another batch of positive data from its respiratory program with the investigational drug depemokimab, this time in patients with chronic rhinosinusitis with nasal

October 15, 2024

Zimmer partners with Think Surgical to launch knee surgery robot

Dive Brief: Zimmer Biomet has partnered with Think Surgical to exclusively distribute a wireless handheld robotic knee surgery device, the companies said Tuesday. The planned

June 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.